The unique aspect of the pathway analysis of this study is that the gene sets for ORA were selected based on the expression correlation with the reference gene, RUNX1T1. The RUNX1T1 expression level in each RNA-seq sample might be skewed by several factors, such as its tumor purity or subclonal heterogeneity. This evidence concerns the gene RUNX1T1 and neoplasm.